Clare Market Investments’s VanEck Pharmaceutical ETF PPH Stock Holding History

Clare Market Investments’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,396	Closed	-$494K	–	165
2024 Q2	$494K	Sell	5,396 -145	-3%	-$12.9K	0.14%	86
2024 Q1	$503K	Sell	5,541 -68	-1%	-$5.95K	0.16%	90
2023 Q4	$456K	Buy	5,609 +33	+0.6%	+$2.59K	0.16%	88
2023 Q3	$445K	Buy	5,576 +694	+14%	+$56K	0.17%	75
2023 Q2	$385K	Buy	4,882 +245	+5%	+$19.2K	0.14%	85
2023 Q1	$360K	Sell	4,637 -50	-1%	-$3.85K	0.15%	80
2022 Q4	$364K	Buy	+4,687	New	+$346K	0.17%	80

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FPGK

Financial Partners Group (Kansas) Overland Park, Kansas $985M AUM 29.69% 1-Year Est. Return

Clare Market Investments's PPH Position: Q3 2024 in Review

Clare Market Investments sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2024, closing a stake of 5,396 shares — an estimated $494K sold.

Clare Market Investments first reported a position in PPH in Q4 2022 and held it in 7 quarters. The position peaked at $503K in Q1 2024. 142 funds tracked by Wall St. Rank hold PPH as of Q3 2024.

Clare Market Investments reported no remaining VanEck Pharmaceutical ETF position as of Q3 2024 after selling out during the quarter.
Clare Market Investments sold 5,396 VanEck Pharmaceutical ETF shares in Q3 2024, an estimated $494K.
Clare Market Investments first reported a position in VanEck Pharmaceutical ETF in Q4 2022 and held it in 7 quarters.
Clare Market Investments's VanEck Pharmaceutical ETF position peaked at $503K in Q1 2024.
142 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2024.

Based on Clare Market Investments's 13F filing for Q3 2024, filed 20 Feb 2025.